BNTC
Benitec Biopharma Ltd
9.00$
-6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +463.4% | +347.5% | -84.1% | -28.0% | -19.6% | -26.9% | -8.5% | +128.4% | +53.0% | +89.5% | -34.1% | -59.0% | -24.2% | +2,146.5% | +296.5% | -99.4% | -39.2% | +23.7% | +2.7% | +188.0% | -100.0% | – | |
| – | – | – | – | +110.9% | -35.1% | -3.2% | -36.4% | +16.6% | -86.3% | -78.3% | -34.1% | +232.0% | +106.6% | +196.2% | +31.3% | -129.7% | – | -92.7% | +4,133.3% | -10.0% | +15.5% | +21.5% | |
| – | – | – | -135.7% | – | – | – | – | – | – | +169.5% | -34.1% | -70.2% | -80.2% | +10,900.9% | +302.8% | -98.2% | -122.7% | – | +17.2% | -557.3% | – | – | |
| – | +194.8% | -27.4% | – | – | +87.1% | +21.7% | -6.7% | +13.1% | +137.6% | +73.8% | -34.1% | +103.8% | -45.0% | -8.5% | -14.3% | -6.0% | +133.9% | +60.6% | +13.3% | +22.2% | +17.4% | +27.6% | |
| – | – | – | – | – | – | – | – | – | – | +77.7% | -34.8% | +39.1% | -18.0% | -11.8% | -31.6% | +72.6% | +17.0% | +2.1% | -4.0% | +9.5% | +235.3% | +18.7% | |
| – | +79.0% | -69.8% | -89.3% | +10.1% | +106.4% | +21.7% | +58.5% | +75.5% | +124.2% | +83.3% | -25.6% | +75.0% | -35.0% | +36.0% | -21.0% | -34.8% | +58.0% | +32.4% | +6.9% | +17.4% | +83.9% | +22.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -324.1% | – | – | – | – | – | – | |
| – | +429.7% | – | – | +351.9% | -58.2% | +1,504.3% | -54.4% | -67.7% | -100.0% | – | – | – | – | – | – | -47.9% | -90.3% | +433.3% | +3.1% | +2,639.4% | +263.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -321.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -1,195.9% | – | – | – | – | -474.1% | – | -99.2% | -20,733.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -321.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -512.7% | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.